calcium gluconate has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, CD | 1 |
| Chan, A; Chay, WY; Chiang, J; Lew, KY | 1 |
2 other study(ies) available for calcium gluconate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders | 2014 |
Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
Topics: Adenocarcinoma; Antineoplastic Agents; Calcium Gluconate; Clinical Trials as Topic; Colonic Neoplasms; Early Termination of Clinical Trials; Humans; Infusions, Intravenous; Magnesium Sulfate; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Research Design; Sensory Receptor Cells | 2011 |